Active substance
Nystatin
- SFDA 12
- US FDA 81
- Health Canada 5
- US price lines 16
- NHS prices 1
- WHO EML 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| MIKOSTAT 100000 U OINTMENT | 100000 IU/g | Ointment · Topical | 1 Tube | SAR 10.00 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| MIKOSTAT 100000U CREAM | 100000 IU | Cream · Topical | 1 Tube | SAR 7.50 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| MIKOSTAT 100000U\ML ORAL SUSP | 100000 IU/ml | Oral suspension · Oral use | 1 Bottle | SAR 9.15 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| MYCOSAT 100,000IU\ML ORAL SUSP | 100000 IU/ml | Suspension · Oral use | 1 Bottle | SAR 7.40 | Generic · Prescription | Amman Pharmaceutical Industries (API) | Valid |
| RIANEST | 100000 IU | Cream · Topical | 1 Tube | SAR 7.50 | Generic · Prescription | RIYADH PHARMA | Valid |
| RIANEST | 100000 IU | Ointment · Topical | 1 Tube | SAR 10.00 | Generic · Prescription | RIYADH PHARMA | Valid |
| RIANEST | 100000 IU | Oral suspension · Oral use | 1 Bottle | SAR 9.15 | Generic · Prescription | RIYADH PHARMA | Valid |
| SINATEN 100000 I.U VAGINAL TAB. | 100000 IU | Vaginal tablet · Vaginal use | 16 Blister | SAR 28.00 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| DERMOSE CUSI NYSTATIN OIN.100000 I.U | 100000 IU | Ointment · Topical | 1 Tube | SAR 6.40 | NCE · Prescription | ALCON CUSI | Withdrawn by MAH · Not Marketed |
| MYCOSTATIN 100000 UNITS-ML ORAL SUSP | 100000 IU/ml | Oral suspension · Oral use | 1 Bottle | SAR 26.65 | NCE · Prescription | BRISTOL-MYERS SQUIBB | Withdrawn by MAH · Not Marketed |
| SINATEN 10 000 IU OINTMENT 15 GM | 100000 IU | Ointment · Topical | 1 Tube | SAR 4.65 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| SINATEN 500000 IU \5ML ORAL SUSP | 100000 IU/ml | Oral suspension · Oral use | 1 Bottle | SAR 7.40 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
FUNGAL INFECTIONS OF THE GENITAL TRACT - CANDIDIASIS OF OTHER UROGENITAL SITES
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NILSTAT | 100,000 UNITS/ML | suspension · oral | CHARTWELL MOLECULES | Prescription | 14 Apr 1971 |
| NYSTATIN | 100,000 UNITS/GM | cream · topical | COSETTE PHARMS NC | Prescription | 25 May 1976 |
| NYSTATIN | 100,000 UNITS/GM | cream · topical | FOUGERA PHARMS | Prescription | 1 Feb 1979 |
| NYSTATIN | 100,000 UNITS/GM | cream · topical | PADAGIS US | Prescription | 11 Dec 1979 |
| NYSTATIN | 100,000 UNITS/GM | ointment · topical | FOUGERA PHARMS | Prescription | 23 Sep 1982 |
| NYSTATIN | 500,000 UNITS | tablet · oral | HERITAGE | Prescription | 22 Dec 1983 |
| NYSTATIN | 500,000 UNITS | tablet · oral | TEVA | Prescription | 16 Jan 1984 |
| NYSTATIN | 100,000 UNITS/GM | ointment · topical | PADAGIS US | Prescription | 13 Feb 1984 |
| NYSTATIN | 100,000 UNITS/ML | suspension · oral | FOUGERA PHARMS INC | Prescription | 7 Jun 1984 |
| NYSTATIN | 100,000 UNITS/ML | suspension · oral | PHARMOBEDIENT | Prescription | 29 Oct 1984 |
| NYSTATIN | 100,000 UNITS/GM | ointment · topical | ACTAVIS MID ATLANTIC | Prescription | 13 Nov 1987 |
| NYSTATIN | 100,000 UNITS/GM | cream · topical | ACTAVIS MID ATLANTIC | Prescription | 13 Jun 1988 |
| NYSTATIN | 100,000 UNITS/ML | suspension · oral | SCIEGEN PHARMS | Prescription | 27 Dec 1991 |
| NYSTATIN | 100,000 UNITS/GM | cream · topical | SUN PHARMA CANADA | Prescription | 29 Jan 1993 |
| NYSTOP | 100,000 UNITS/GM | powder · topical | PADAGIS US | Prescription | 16 Aug 1996 |
| NYSTATIN | 100,000 UNITS/GM | powder · topical | DR REDDYS LABS SA | Prescription | 15 Jul 2004 |
| NYSTATIN | 100,000 UNITS/GM | powder · topical | LUPIN | Prescription | 23 Jul 2004 |
| NYSTATIN | 100,000 UNITS/GM | powder · topical | UPSHER SMITH LABS | Prescription | 3 May 2005 |
| NYSTATIN | 100,000 UNITS/ML | suspension · oral | GENUS | Prescription | 28 Jun 2005 |
| NYSTATIN | 100,000 UNITS/ML | suspension · oral | PHARM ASSOC | Prescription | 7 Jan 2016 |
| NYSTATIN | 100,000 UNITS/GM | powder · topical | LYNE | Prescription | 30 May 2017 |
| NYSTATIN | 100,000 UNITS/GM | powder · topical | ZYDUS PHARMS | Prescription | 8 Jun 2017 |
| NYSTATIN | 100,000 UNITS/GM | cream · topical | CROWN LABS INC | Prescription | 26 Sep 2017 |
| NYSTATIN | 100,000 UNITS/GM | ointment · topical | COSETTE | Prescription | 6 Oct 2017 |
| KLAYESTA | 100,000 UNITS/GM | powder · topical | EPIC PHARMA LLC | Prescription | 30 Apr 2018 |
56 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| JAMP-NYSTATIN ORAL SUSPENSION USP | 02433443 | 100000 UNIT / ML | SUSPENSION · ORAL | JAMP PHARMA CORPORATION |
| NYADERM | 00716871 | 100000 UNIT / G | CREAM · TOPICAL | TARO PHARMACEUTICALS INC |
| NYADERM | 00716901 | 25000 UNIT / G | CREAM · VAGINAL | TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC. |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 00792667 | 100000 UNIT / ML | SUSPENSION · ORAL | PHARMASCIENCE INC |
| TEVA-NYSTATIN | 02194201 | 100000 UNIT / ML | SUSPENSION · ORAL | TEVA CANADA LIMITED |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | KLAYESTA 100,000 UNIT/GM POWD | $0.42143 | per GM | 23 Sep 2026 |
| US NADAC | KLAYESTA 100,000 UNIT/GM POWD | $0.31335 | per GM | 23 Sep 2026 |
| US NADAC | KLAYESTA 100,000 UNIT/GM POWD | $0.25738 | per GM | 23 Sep 2026 |
| US NADAC | NYSTATIN 100,000 UNIT/GM CREAM | $0.19826 | per GM | 23 Sep 2026 |
| US NADAC | NYSTATIN 100,000 UNIT/GM CREAM | $0.15101 | per GM | 23 Sep 2026 |
| US NADAC | NYSTATIN 100,000 UNIT/GM OINT | $0.23306 | per GM | 23 Sep 2026 |
| US NADAC | NYSTATIN 100,000 UNIT/GM OINT | $0.23754 | per GM | 23 Sep 2026 |
| US NADAC | NYSTATIN 100,000 UNIT/GM POWD | $0.42143 | per GM | 23 Sep 2026 |
| US NADAC | NYSTATIN 100,000 UNIT/GM POWD | $0.31335 | per GM | 23 Sep 2026 |
| US NADAC | NYSTATIN 100,000 UNIT/GM POWD | $0.25738 | per GM | 23 Sep 2026 |
| US NADAC | NYSTATIN 100,000 UNIT/ML SUSP | $0.13995 | per ML | 23 Sep 2026 |
| US NADAC | NYSTATIN 100,000 UNIT/ML SUSP | $0.05693 | per ML | 30 Sep 2026 |
| NHS Drug Tariff | Nystatin 100,000units/ml oral suspension | £9.75 | 30 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 6.3. Antifungal medicines · core
Candidosis
Oral > Liquid: 100000 IU per mL (EMLc) | Local > Topical > Other: 100000 IU pessary (EML) | Oral > Solid > dosage form: 500000 IU | Oral > Solid > lozenge: 100000 IU
Combinations containing Nystatin
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.